A Facebook billionaire makes a major investment in immunotherapy.
A genetic technology that can kill off mosquito species could eradicate malaria. But is it too risky to ever use?
A portable assembly line for medicines offers a better way to respond to outbreaks and shortages.
Clues to novel treatments could be gleaned from people who aren’t sick, but should be.
The attempt is another controversial test of whether gene-modified people are possible.
How one nonprofit’s mailroom is making tinkering with genomes as easy as shopping at Amazon.
Beth Stevens thinks she has solved a mystery behind brain disorders such as Alzheimer’s and schizophrenia.
A government investigation of Theranos’s lab has documented a host of troubles at the blood-testing startup.
U.S. and Finnish doctors caught the brain-shrinking virus in action and say tests to screen for such problems are possible.
The world’s deadliest mosquito-borne disease, malaria, is in decline. But illnesses transmitted by a different mosquito, which include Zika and dengue, have increased sharply since the city-dwelling Aedes aegypti reinvaded the Americas.